CAS 254964-60-8 appears in our catalog under these names: Tasquinimod, Tasquinimod/ 99.5% (existing batch purity), Tasquinimod 98%, Tasquinimod, 98%, 98%, Tasquinimod, 99.94%. Offered by: TRC, GLPBio, TargetMol, Ambeed, Chemat. Available pack sizes: 250mg, 10mg, 200mg, 5mg, 10mM (in 1ml dmso), 50mg, 1mg, 2mg.
Tasquinimod is a quinoline-3-carboxamide linomide analogue with antiangiogenic and potential antineoplastic activities. Tasquinimod has been shown to decrease blood vessel density but the exact mechanism of action is not known. This agent has also been shown to augment the antineoplastic effects of docetaxel and androgen ablation in a murine model of prostate cancer involving human prostate cancer xenografts.
Source: ChEBI
| Molecular formula | C20H17F3N2O4 |
|---|---|
| Molecular weight | 406.4 g/mol |
| IUPAC name | 4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[4-(trifluoromethyl)phenyl]quinoline-3-carboxamide |
| InChIKey | ONDYALNGTUAJDX-UHFFFAOYSA-N |
| SMILES | CN1C2=C(C(=CC=C2)OC)C(=C(C1=O)C(=O)N(C)C3=CC=C(C=C3)C(F)(F)F)O |
Computed by PubChem (NCBI)